Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert Panel

Cancer statistics, 2022

Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2022 · 17.9K citations · Full text

Epidemiology Of Cancer, Population Health Sciences, Cancer Registration +18

Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer

Robert Timmerman, Ronald C. McGarry, Constantin T. Yiannoutsos et al. · Journal of Clinical Oncology · 2006 · 1.5K citations · Full text

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

David S. Ettinger, Douglas E. Wood, Dara L. Aisner et al. · Journal of the National Comprehensive Cancer Network · 2022 · 1.4K citations

Version 3.2022, Advanced Lung Disease, Medicine +15

Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues

Søren M. Bentzen, Louis S. Constine, Joseph O. Deasy et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 1.2K citations · Full text

Quantitative Analysis, Scientific Issues, Laboratory Medicine +5

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Journal of Clinical Oncology · 2022 · 1.2K citations · Full text